ISS Clinical Trials in New York, New York
32 recruitingNew York, New York
Showing 1–20 of 32 trials
Recruiting
Phase 3
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Metastatic Dedifferentiated LiposarcomaStage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8+3 more
National Cancer Institute (NCI)365 enrolled248 locationsNCT06422806
Recruiting
Not Applicable
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Type B Aortic Dissection
Duke University1,100 enrolled63 locationsNCT06087029
Recruiting
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
Soft Tissue Lesion
Galvanize Therapeutics, Inc.1,000 enrolled10 locationsNCT05851430
Recruiting
Phase 3
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Soft Tissue Sarcoma
Polaris Group300 enrolled31 locationsNCT05712694
Recruiting
Phase 1Phase 2
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Soft Tissue SarcomaSarcomaSarcoma,Soft Tissue+1 more
Memorial Sloan Kettering Cancer Center98 enrolled1 locationNCT04577014
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Head and Neck CarcinomaMalignant Solid NeoplasmSarcoma+59 more
Alliance for Clinical Trials in Oncology2,000 enrolled745 locationsNCT05334069
Recruiting
Phase 1
Actinium Therapy for Late-stage Aggressive Sarcomas
Advanced Soft Tissue Sarcoma
Ratio Therapeutics, Inc.30 enrolled6 locationsNCT07156565
Recruiting
Phase 2
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
Soft Tissue Sarcoma
QBiotics Group Limited40 enrolled1 locationNCT05755113
Recruiting
Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Breast CancerUrothelial CarcinomaSoft Tissue Sarcoma+2 more
Avacta Life Sciences Ltd158 enrolled9 locationsNCT04969835
Recruiting
Phase 1Phase 2
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Metastatic Soft Tissue SarcomaUnresectable Soft Tissue Sarcoma
Adcendo ApS270 enrolled8 locationsNCT06797999
Recruiting
Not Applicable
Improving the Mental Health of Home Health Aides
Mental Health Issue
Weill Medical College of Cornell University100 enrolled2 locationsNCT06071221
Recruiting
Not Applicable
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
Aortic Aneurysm, ThoracoabdominalAortic Aneurysm, ThoracicAortic Dissection, Thoracoabdominal
Darren Schneider, M.D.520 enrolled2 locationsNCT02323581
Recruiting
Not Applicable
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
Hearing LossHospital ReadmissionEmergency Service
VA Office of Research and Development1,050 enrolled6 locationsNCT05028972
Recruiting
Phase 1
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
Soft Tissue SarcomaMelanomaEwing Sarcoma+2 more
Iovance Biotherapeutics, Inc.40 enrolled5 locationsNCT06566092
Recruiting
Not Applicable
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
Soft Tissue SarcomaSarcomaBone Sarcoma
Memorial Sloan Kettering Cancer Center60 enrolled8 locationsNCT06129903
Recruiting
Not Applicable
Prevention of Psychological Health Problems Via Integrated Operational Support
Depression, AnxietyGriefLeadership+1 more
New York University5,586 enrolled1 locationNCT06981598
Recruiting
Phase 1
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Hematologic MalignancyGvHDGVHD,Acute+8 more
Tr1X, Inc.36 enrolled5 locationsNCT06462365
Recruiting
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry
Spontaneous Coronary Artery Dissection
SCAD Alliance1,000 enrolled31 locationsNCT04496687
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+3 more
GI Innovation, Inc.358 enrolled11 locationsNCT05824975
Recruiting
Not Applicable
Early Feeding After Oral Cavity Reconstruction
Head and Neck CancerFree Tissue Transfer
Icahn School of Medicine at Mount Sinai89 enrolled1 locationNCT04787939